The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
Clinical trial NCT03419624 · TERMINATED
Trial details
- NCT number
- NCT03419624
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-19
- Primary completion
- 2019-04-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.